Compliance Rate

Compliance Rate 47.06%
Compliant submissions 8
Incompliant submissions 9
Total trials 17

My Organizations' Clinical Trials

Showing 325 of 867 entries
View as:

COVID-19 Convalescent Plasma

Phase: N/A Priority: Normal
NCT ID: NCT04340050 Org: User:
Start: 04/10/20 End: 12/23/20 Due: 12/23/21

Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00519077 Org: User:
Start: 03/31/05 End: 05/31/13 Due: 05/31/14

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00004141 Org: User:
Start: 08/31/98 End: 04/30/06 Due: 04/30/07

Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine

Phase: N/A Priority: Normal
NCT ID: NCT00053222 Org: User:
Start: 02/28/03 End: 07/31/07 Due: 07/31/08

Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00203853 Org: User:
Start: 01/31/05 End: 03/31/07 Due: 03/31/08

Thirty Million Words-Early Childhood Educator (TMW-ECE)

Phase: N/A Priority: Normal
NCT ID: NCT04027673 Org: User:
Start: 06/03/19 End: 03/30/20 Due: 03/30/21

Marinol in Trichotillomania or Obsessive Compulsive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01093976 Org: User:
Start: 04/30/10 End: 02/28/11 Due: 02/28/12

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Phase: N/A Priority: Normal
NCT ID: NCT00814528 Org: User:
Start: 11/30/07 End: 09/30/09 Due: 09/30/10

Brain Function and EEG

Phase: N/A Priority: Normal
NCT ID: NCT05003076 Org: User:
Start: 07/01/21 End: 04/01/23 Due: 04/01/24

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Phase: N/A Priority: Normal
NCT ID: NCT06171152 Org: User:
Start: 01/26/24 End: 10/01/26 Due: 10/01/27

DBS Frequency on Swallowing Function in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01935011 Org: User:
Start: 08/31/13 End: 07/31/14 Due: 07/31/15

Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01185171 Org: User:
Start: 01/27/03 End: 08/31/18 Due: 08/31/19

Trial of Adalimumab in Progressive Sarcoidosis

Phase: N/A Priority: Normal
NCT ID: NCT00311246 Org: User:
Start: 04/30/06 End: 09/30/08 Due: 09/30/09

Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00449280 Org: User:
Start: 11/30/06 End: 09/30/09 Due: 09/30/10

Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization

Phase: N/A Priority: Normal
NCT ID: NCT03305874 Org: User:
Start: 03/07/18 End: 07/17/23 Due: 07/17/24

Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois

Phase: N/A Priority: Normal
NCT ID: NCT00817492 Org: User:
Start: 07/31/06 End: 06/30/11 Due: 06/30/12

Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology

Phase: N/A Priority: Normal
NCT ID: NCT02659787 Org: User:
Start: 06/30/16 End: 04/30/17 Due: 04/30/18

Oxalate and Citrate

Phase: N/A Priority: Normal
NCT ID: NCT05334979 Org: User:
Start: 10/27/22 End: 07/01/25 Due: 07/01/26

Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)

Phase: N/A Priority: Normal
NCT ID: NCT00117572 Org: User:
Start: 11/30/04 End: 12/31/16 Due: 12/31/17

Youth Drug Abuse Prevention in Kazakhstan

Phase: N/A Priority: Normal
NCT ID: NCT01969305 Org: User:
Start: 01/31/14 End: 05/31/16 Due: 05/31/17

REACH-OUT: Chicago Children's Diabetes Prevention Program

Phase: N/A Priority: Normal
NCT ID: NCT00723853 Org: User:
Start: 04/30/08 End: 04/30/12 Due: 04/30/13

Intranasal Steroids and Oxymetazoline in Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00584987 Org: User:
Start: 06/30/07 End: 07/31/09 Due: 07/31/10

Lifestyle Intervention Feasibility for Arrhythmia and Symptoms With Intermittent Fasting (LIFE AS IF)

Phase: N/A Priority: Normal
NCT ID: NCT04090840 Org: User:
Start: 08/01/19 End: 01/30/21 Due: 01/30/22

Sleep Loss and Glucose Metabolism in People With Family History of Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00721019 Org: User:
Start: 07/31/08 End: 03/31/12 Due: 03/31/13

Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00361439 Org: User:
Start: 08/31/06 End: 09/30/08 Due: 09/30/09